Imagine reducing the time to identify a drug that shows results in the clinic to five years: this proof-of-concept study shows it is possible now

June 9, 2022

Imagine reducing the time to identify a drug that shows results in the clinic to five years: this proof-of-concept study shows it is possible now

The study identifies the first clinical candidate developed using HUB Organoids® and high-content screening that inhibits tumor growth and metastasis in colorectal...

read more

MIMETAS Expands Adult Stem Cell Organoid License to All Organs

May 26, 2022

MIMETAS Expands Adult Stem Cell Organoid License to All Organs

Leiden, The Netherlands, May 3, 2022 – MIMETAS, a global leader in Organ-on-a-Chip models and technology, announces today that it has expanded its...

read more

First Clinical Candidate Developed using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer

May 25, 2022

First Clinical Candidate Developed using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer

San Diego, California, April 28, 2022 – Crown Bioscience, a JSR Life Sciences company, and HUB Organoids (HUB) announced today the publication of preclinical data...

read more

Exclusive interview with Dr Carla Verissimo

February 17, 2022

Exclusive interview with Dr Carla Verissimo

Our Carla Verissimo, Head of Oncology II speaks about the current challenges of oncology drug development in this exclusive interview of the...

read more

New PERSIST-SEQ program launched

February 17, 2022

New PERSIST-SEQ program launched

2 September 2021, Utrecht (The Netherlands) - Hubrecht Organoid Technology (HUB) joins a new international consortium of academic and industrial leaders in...

read more

New service partnership

February 17, 2022

New service partnership

VANCOUVER, British Columbia - STEMCELL Technologies and Hubrecht Organoid Technology (HUB) have announced that they have signed an agreement for the use...

read more

HUB at Innovation Parade

February 17, 2022

HUB at Innovation Parade

HUB takes centre stage during this year’s Olympic games in Tokyo by sponsoring the Innovation Parade, an online event organized by the Embassy of the Kingdom of The...

read more

HUB and Yamaha for IVD

February 17, 2022

HUB and Yamaha for IVD

April 26, 2021 - Hubrecht Organoid Technology (HUB) and Yamaha Motor Co., Ltd. (Tokyo:7272) announced today continuation of their collaboration to provide...

read more

Next-gen diagnostics

February 17, 2022

Next-gen diagnostics

Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they have signed a Memorandum of Understanding (MoU) to form a...

read more

Ovarian cancer organoids

February 17, 2022

Ovarian cancer organoids

Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of high-grade serous ovarian cancer...

read more

X

Have any questions?

contact us